Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-27

FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for Esomeprazole Magnesium, a generic proton pump inhibitor, marking a routine regulatory acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole magnesium (esomeprazole magnesium)

Snippet

SUPPL AP for ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)